Rhodamine
110 (Rh110)-labeled peptides are used in the study of a number of protease activity,
such as cysteine aspartate-specific proteases and serine
proteases.1-2 Rhodamine 110 (Figure 1) contains two amino groups
available for conjugation to the C-terminal end of a peptide or amino acid.
Protease cleavage of the non-fluorescent bis-substituted rhodamine 110 peptide
derivatives result in monosubstituted rhodamine 110 and free rhodamine 110,
both of which are fluorescent.1 Fluorescence intensity can therefore
be correlated to protease activity.
Rhodamine110 conjugated to charged amino acids are generally cell permeable.
As a results, these substrates can be used in intact cells for applications
such as flow cytometry.2 Rhodamine labeled peptides affords significant
advantages over AFC or AMC labeled peptides in that Rh110 emits in the green
range (Ex/Em=501/527nm), while AMC (Ex/Em=340/440 nm) and AFC (Ex/Em=370/500
nm) emits in the blue range. Autofluorescence interference from cellular components
is minimal, making the substrates more sensitive. Rhodamine 110-peptide conjugates
are also not pH dependent.1
Figure 1. Molecular structure of Rhodamine 110.
AnaSpec is
pleased that our Rhodamine 110 labeled peptides, especially the caspase substrates
have long been used and trusted by researchers. As part of our GO™ (catalog)
peptides, these peptides are rigorously QC’d (3 times) using mass spec and HPLC
(>95% purity). For custom peptide synthesis inquiries, please contact service@anaspec.com.
Other labels include our proprietary HiLyte Fluor dyes, classic dyes (FAM, Sulforhodamine
101), pNA, aminoluciferin, and others.
| Product |
Size |
Cat# |
| Caspase 1 (ICE) Substrate 2r, fluorogenic
(Ac - YVAD)2 - Rh110 |
1 mg |
60310-1 |
| Caspase 1 (ICE) Substrate 3r, fluorogenic
(Ac - WEHD)2 - Rh110 |
1 mg |
60309-1 |
| Caspase 2 Substrate 3r
(D)2 - Rh110 |
1 mg |
60313-1 |
| Caspase 3 (Apopain) Substrate 1r - z, fluorogenic
(Z - DEVD)2 - Rh110 |
5 mg |
60304-5 |
| Caspase 3 Substrate 1r, fluorogenic
(Ac - DMQD)2 - Rh110 |
1 mg |
60305-1 |
| Caspase 4 (ICH - 2) Substrate 1r, fluorogenic
(Ac - LEVD)2 - Rh110 |
1 mg |
60307-1 |
| Caspase 6 (Mch2) Substrate 1r, fluorogenic
(Ac - VEID)2 - Rh110 |
1 mg |
60308-1 |
| Caspase 8 Substrate 1r - z, fluorogenic
(Z - IETD)2 - Rh110 |
1 mg
5 mg |
60312-1
60312-5 |
| Caspase 9 Substrate 1r, fluorogenic
(Ac - LEHD)2 - Rh110 |
1 mg |
60306-1 |
| (Z - AA)2Rh110 Calpain Substrate
[Rhodamine 110, bis - (CBZ - L - alanyl - L - alanine
amide)] |
5 mg |
60320-5 |
| (Z - Ala - Ala - Ala - Ala)2Rh110 Elastase Substrate
[Rhodamine 110, bis - (CBZ - L - alanyl - L - alanyl
- L - alanyl - L - alanine amide)] |
5 mg |
60321-5 |
| (Z - AR)2Rh110•2HCl Elastase Substrate
[Rhodamine 110, bis - (CBZ - L - alanyl - L - arginine
amide)] |
5 mg |
60322-5 |
| (Z - Arg)2Rh110 • 2HCl Trypsin, Cathepsin B and
L Substrate
[Rhodamine 110, bis - (CBZ - L - arginine amide)] |
5 mg |
60323-5 |
| (Z - Phe - Arg)2Rh110
(Z - FR)2Rh110 |
1 mg
5 mg |
27201
27202 |
References:
1. Rothe, G. et al. Biol. Chem. Hoppe-Seyler
373, 547 (1992).
2. Hug, H. et al. Biochem. 38, 13906
(1999).
|